It has been reported that glioma tumors have elevated levels of the anti-apoptotic proteins Bcl-2 and reduced levels of the apoptotic protein Bax, giving rise to a predisposed anti-apoptotic state correlated with resistance to chemotherapy. The gene discussed is BAX; the disease is central nervous system cancer.